Silk Road Medical (NASDAQ:SILK) Research Coverage Started at

B. Riley started coverage on shares of Silk Road Medical (NASDAQ:SILK – Get Rating) in a research report sent to investors on Friday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $58.00 price objective on the stock. Other equities analysts have also recently issued reports about the company. Citigroup upgraded Silk Road […]

Related Keywords

Richard Ruedy , Company Profile , Pricet Rowe Associates Inc , Hightower Advisors , Citigroup , Wells Fargo Company , Nasdaq , Financial Services Group Inc , Wolfe Research , Silk Road Medical , Get Rating , Moderate Buy , Road Medical , Director Elizabeth , Services Group , Tower Advisors , Silk Road Medical Daily , Nasdaq Silk , Silk , Medical , Initiated Coverage , B Riley ,